4886

JP:CO:ASKA-PHARMA-HD

あすか製薬ホールディングス株式会社

  • Stock

Last Close

2,036.00

22/11 06:45

Market Cap

67.99B

Beta: -

Volume Today

28.50K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Mar '14
Jun '14
Sep '14
Dec '14
Mar '15
Jun '15
Sep '15
Dec '15
Mar '16
Jun '16
Sep '16
Dec '16
Mar '17
Jun '17
Sep '17
Dec '17
Mar '18
Jun '18
Sep '18
Dec '18
Mar '19
Jun '19
Sep '19
Dec '19
Mar '20
Jun '20
Sep '20
Dec '20
Mar '21
Jun '21
Sep '21
Dec '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
Jun '24
net income
759M
-
-786M
203.56%
295M
137.53%
541M
83.39%
645M
19.22%
-288M
144.65%
187M
164.93%
208M
11.23%
685M
229.33%
-379M
155.33%
526M
238.79%
749M
42.40%
2.63B
251.80%
-966M
136.66%
1.04B
207.97%
600M
42.47%
1.38B
130.50%
-638M
146.13%
1.06B
266.46%
-319M
130.04%
1.47B
561.76%
-472M
132.04%
563M
219.28%
14M
97.51%
487M
3,378.57%
-415M
185.22%
739M
278.07%
813M
10.01%
899M
10.58%
262M
70.86%
1.10B
319.08%
-3.89B
454.64%
6.88B
276.63%
208M
96.98%
1.32B
536.06%
1.02B
22.68%
1.84B
79.57%
55M
97.01%
1.43B
2,496.36%
2.70B
89.15%
2.33B
13.77%
1.09B
53.33%
1.27B
17.11%
depreciation and amortization
769M
-
790M
2.73%
810M
2.53%
679M
16.17%
697M
2.65%
715M
2.58%
deferred income tax
stock based compensation
change in working capital
accounts receivables
inventory
accounts payables
other working capital
other non cash items
-759M
-
786M
203.56%
-295M
137.53%
-541M
83.39%
-645M
19.22%
288M
144.65%
-187M
164.93%
-208M
11.23%
-685M
229.33%
379M
155.33%
-526M
238.79%
-749M
42.40%
-2.63B
251.80%
966M
136.66%
-1.04B
207.97%
-600M
42.47%
-1.38B
130.50%
638M
146.13%
-1.06B
266.46%
319M
130.04%
-1.47B
561.76%
472M
132.04%
-563M
219.28%
-14M
97.51%
-487M
3,378.57%
415M
185.22%
-739M
278.07%
-813M
10.01%
-899M
10.58%
-262M
70.86%
-1.10B
319.08%
3.89B
454.64%
-6.88B
276.63%
-208M
96.98%
-1.32B
536.06%
-254M
80.80%
-1.05B
312.20%
755M
172.11%
-749M
199.21%
-2.00B
167.56%
-1.61B
19.46%
-1.09B
32.65%
-1.27B
17.11%
net cash provided by operating activities
1.54B
-
1.58B
2.73%
1.62B
2.53%
1.36B
16.17%
1.39B
2.65%
1.43B
2.58%
investments in property plant and equipment
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites
debt repayment
common stock issued
common stock repurchased
dividends paid
other financing activites
net cash used provided by financing activities
effect of forex changes on cash
net change in cash
-467M
-
1.28B
374.09%
-999M
178.05%
-2.32B
132.43%
4.26B
283.59%
-1.99B
146.73%
cash at beginning of period
17.69B
-
17.22B
2.64%
18.50B
7.43%
17.50B
5.40%
15.18B
13.26%
19.45B
28.08%
cash at end of period
17.22B
-
18.50B
7.43%
17.50B
5.40%
15.18B
13.26%
19.45B
28.08%
17.45B
10.24%
operating cash flow
1.54B
-
1.58B
2.73%
1.62B
2.53%
1.36B
16.17%
1.39B
2.65%
1.43B
2.58%
capital expenditure
free cash flow
1.54B
-
1.58B
2.73%
1.62B
2.53%
1.36B
16.17%
1.39B
2.65%
1.43B
2.58%

All numbers in (except ratios and percentages)